As a preclinical CRO specializing in oncology, Alfa Cytology provides comprehensive gene function study services spanning both in vitro and in vivo platforms to systematically evaluate the impact of genes on tumor biological behaviors. Leveraging advanced gene modulation tools (overexpression, knockout, knockdown, and point mutation) and a diverse array of phenotypic detection platforms, our senior scientists are dedicated to delivering high-quality, reproducible functional study solutions tailored to meet your specific research needs.
Gene function studies are central to cancer biology and drug discovery, elucidating how specific genes drive tumor initiation, progression, metastasis, drug resistance, and therapeutic response. These studies distinguish driver genes that promote malignancy from passenger mutations with no growth advantage, providing a molecular framework for understanding cancer pathogenesis. Through gain-of-function (overexpression) and loss-of-function (knockout/knockdown) approaches, researchers can characterize gene roles in tumor cells and the microenvironment. Gain-of-function studies reveal oncogenic potential and identify genes driving proliferation, survival, or invasion. Loss-of-function studies expose genes essential for tumor maintenance, revealing therapeutically exploitable vulnerabilities.Beyond driver identification, gene function studies dissect downstream signaling pathways, including proliferation, apoptosis, metabolism, DNA repair, and immune evasion. They also enable assessment of target dependency across genetic contexts, uncovering context-specific vulnerabilities, synthetic lethal interactions, and resistance mechanisms.
Fig. 1 Single-cell RNA sequencing analysis revealed PRR15 overexpression within the malignant cell population of NSCLC tumors. (Ji Y, et al.; 2025)
Alfa Cytology's gene function study services encompass the core dimensions of your research needs, comprising both in vitro and in vivo modules. Each research project is subjected to rigorous experimental design and comprehensive data validation to ensure the reliability, reproducibility, and translational potential of the results.
In Vitro Gene Function Studies
Our in vitro gene function study services utilize cell-based models to systematically evaluate the effects of genes on tumor cell phenotypes including proliferation, apoptosis, migration, invasion, drug resistance, and metabolism. We support a broad range of gene modulation strategies, including overexpression, knockout, knockdown, and point mutation, in combination with a diverse array of functional detection methods (CCK-8, flow cytometry, Transwell, 3D culture, organoids, etc.) to comprehensively dissect gene function and deliver high-quality, quantifiable functional data for your target screening research.
Our in vivo gene function study services employ mouse models to assess the biological functions of genes within the context of an intact organism. Utilizing delivery systems such as lentivirus and AAV, or gene editing technologies, we support gene modulation (overexpression/knockout/knockdown) in CDX, PDX, and GEMM models. Combined with in vivo imaging (bioluminescence, fluorescence), tumor growth monitoring, histopathological analysis, and molecular biomarker detection, we systematically evaluate the impact of genes on tumor growth, metastasis, angiogenesis, immune microenvironment remodeling, and drug response, providing critical in vivo evidence for target validation and drug development.
| Study Strategy | In Vitro | In Vivo | Key Readout Metrics |
| Gain-of-Function | Overexpression vector transfection; cell proliferation/migration/apoptosis assays | Overexpressing tumor cell line CDX models; AAV-mediated tissue-specific overexpression | Cell viability, colony formation, tumor volume, survival |
| Loss-of-Function | CRISPR/Cas9 knockout; shRNA knockdown; cellular phenotypic screening | Knockout/knockdown tumor cell line CDX models; conditional knockout GEMMs | Proliferation inhibition, apoptosis induction, tumor regression, target dependency |
| Point Mutation Function | Mutant overexpression; isogenic cell line comparison | Mutant knock-in CDX/GEMM models | Gain-/loss-of-function phenotypes, signaling pathway alterations, drug resistance |
| Drug Resistance Mechanisms | Establishment of resistant cell lines; drug sensitivity resensitization following genetic modulation | Resistant CDX/PDX models; combination therapy evaluation | IC50 shifts, combination efficacy, biomarker changes |
Target Discovery
Target Validation
Mechanistic Studies
Preclinical Evaluation
To support your gene function studies across different research stages, we offer a comprehensive range of in vitro and in vivo models:
| In Vitro | In Vivo |
Project Consultation and Experimental Design
Collaborate with the client to define research objectives, select target genes, and determine modulation strategies (overexpression/knockout/knockdown/point mutation). Develop comprehensive in vitro and in vivo plans covering cell and animal models, phenotypic readouts, and timelines.
Gene Modulation Construction
Construct gene modulation tools: expression vectors for overexpression, sgRNA/Cas9 for knockout, shRNA/siRNA for knockdown, or mutant constructs/isogenic cell lines for point mutation studies. All constructs undergo sequence verification and functional validation.
In Vitro Gene Function Studies
Conduct systematic phenotypic characterization in tumor cell lines following gene modulation. Perform functional assays including proliferation, apoptosis and cell cycle, migration/invasion, and 3D culture/organoid models. Assess drug response changes and elucidate downstream signaling pathways via Western blot, qRT-PCR, immunofluorescence, and RNA-seq.
In Vivo Gene Function Studies
Validate gene function in physiologically relevant animal models (CDX, PDX, or GEMM). Monitor tumor growth, metastasis, and survival using in vivo imaging. Perform histopathological analysis (H&E, IHC), biomarker assessment, and immune microenvironment evaluation. Collect data including tumor growth curves, survival analysis, and pharmacodynamic endpoints.
Data Analysis, Validation, and Reporting
Integrate and analyze data from both in vitro and in vivo studies. Cross-validate findings to confirm consistency and biological relevance. Deliver a comprehensive report summarizing methods, results, and interpretations to support target prioritization and drug discovery decisions.
Integrated In Vitro and In Vivo Platform
A complete gene function research system spanning from cellular assays to animal models, enabling seamless transitions to accelerate project timelines.
Multiple Gene Modulation Strategies
Support for a full range of approaches including overexpression, knockout, knockdown, and point mutation to accommodate diverse research needs.
Comprehensive Assay Systems
Extensive phenotypic readouts covering proliferation, apoptosis, migration, invasion, angiogenesis, and immune microenvironment analysis.
Alfa Cytology combines a comprehensive gene function research platform with rigorous project management and exceptional scientific expertise. Whether you are conducting basic mechanistic exploration, target discovery and validation, or advancing drug candidates toward clinical translation, we are your trusted partner in accelerating cancer research. Please feel free to contact us to discuss your project and learn how Alfa Cytology can support your drug discovery journey.
Reference
For research use only.
Alfa Cytology, a preclinical research solution provider, provides its clients with one-stop solutions to accelerate cancer therapeutics discovery and development.
Copyright © 2026 Alfa Cytology. All rights reserved.
